Acute Biphenotypic Leukemia

Observed

→ investigated in trials for

Cyclophosphamidesmall molecule

13 trials (5 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Cytarabinesmall molecule

7 trials (3 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Venetoclaxsmall molecule

7 trials (4 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Thiotepasmall molecule

6 trials (2 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Busulfansmall molecule

5 trials (2 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Cladribinesmall molecule

5 trials (3 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Filgrastimother

5 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Azacitidinesmall molecule

4 trials (2 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Methotrexatesmall_molecule

4 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Rituximabmonoclonal antibody

4 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Clofarabinesmall molecule

3 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Idarubicinsmall molecule

3 trials (2 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Melphalansmall molecule

3 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Mitoxantronesmall molecule

3 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Sirolimussmall molecule

2 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Sorafenibsmall molecule

2 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Decitabinesmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Dexamethasonesmall_molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Enasidenibsmall molecule

1 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Gilteritinibsmall molecule

1 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Ibrutinibsmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Ipilimumabmonoclonal antibody

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Lenalidomidesmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Midostaurinsmall molecule

1 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Nivolumabmonoclonal antibody

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Omacetaxine Mepesuccinatesmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Quizartinibsmall molecule

1 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Sorafenib Tosylatesmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Tisagenlecleucelcell therapy

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Treosulfansmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Vincristinesmall_molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

Acute Biphenotypic Leukemia studied in …STUDIED_INderived10 of 41show all (up to 200)
→ studied in	NCT03779854Phase 2 · active not recruiting Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant · condition mapped ONTOLOGY_EXACT · 41 trials mapped (14 active)	—	—	Acute Biphenotypic Leukemia	1	Observed	clinicaltrials	graph →
→ studied in	NCT03683433Phase 2 · recruiting Enasidenib and Azacitidine in Treating Patients With Recurrent or Refractory Acute Myeloid Leukemia and IDH2 Gene Mutation · condition mapped ONTOLOGY_EXACT · 41 trials mapped (14 active)	—	—	Acute Biphenotypic Leukemia	1	Observed	clinicaltrials	graph →
→ studied in	NCT04128501Phase 2 · active not recruiting Venetoclax and Azacitidine for the Treatment of Acute Myeloid Leukemia in the Post-Transplant Setting · condition mapped ONTOLOGY_EXACT · 41 trials mapped (14 active)	—	—	Acute Biphenotypic Leukemia	1	Observed	clinicaltrials	graph →
→ studied in	NCT07819396Phase 2 · not yet recruiting Depletion of CD45RA Positive Naive T Cells for the Prevention of Graft Versus Host Disease in Older Patients Undergoing Allogeneic Hematopoietic Cell Transplantation for Acute Leukemia or Myelodysplastic Syndrome · condition mapped ONTOLOGY_EXACT · 41 trials mapped (14 active)	—	—	Acute Biphenotypic Leukemia	1	Observed	clinicaltrials	graph →
→ studied in	NCT05589896Phase 1/Phase 2 · active not recruiting A First-in-Human Study of HLA-Partially to Fully Matched Allogenic Cryopreserved Deceased Donor Bone Marrow Transplantation for Patients With Hematologic Malignancies · condition mapped ONTOLOGY_EXACT · 41 trials mapped (14 active)	—	—	Acute Biphenotypic Leukemia	1	Observed	clinicaltrials	graph →
→ studied in	NCT07710781NA · not yet recruiting Study to Characterize Mismatched to Fully HLA-Matched Ossium HPC, Marrow and Living Donor Transplantation in Patients With Hematologic Malignancies · condition mapped ONTOLOGY_EXACT · 41 trials mapped (14 active)	—	—	Acute Biphenotypic Leukemia	1	Observed	clinicaltrials	graph →
→ studied in	NCT02159495Phase 1 · active not recruiting Genetically Modified T-cell Immunotherapy in Treating Patients With Relapsed/Refractory Acute Myeloid Leukemia and Persistent/Recurrent Blastic Plasmacytoid Dendritic Cell Neoplasm · condition mapped ONTOLOGY_EXACT · 41 trials mapped (14 active)	—	—	Acute Biphenotypic Leukemia	1	Observed	clinicaltrials	graph →
→ studied in	NCT02727803Phase 2 · recruiting Personalized NK Cell Therapy in CBT · condition mapped ONTOLOGY_EXACT · 41 trials mapped (14 active)	—	—	Acute Biphenotypic Leukemia	1	Observed	clinicaltrials	graph →
→ studied in	NCT04975919Phase 2 · active not recruiting Venetoclax in Combination With Decitabine and Cedazuridine for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia · condition mapped CURATED_BROADER · 41 trials mapped (14 active)	—	—	Acute Biphenotypic Leukemia	1	Observed	clinicaltrials	graph →
→ studied in	NCT03399773Phase 2 · active not recruiting Infusion of Expanded Cord Blood Cells in Addition to Single Cord Blood Transplant in Treating Patients With Acute Leukemia, Chronic Myeloid Leukemia, or Myelodysplastic Syndromes · condition mapped ONTOLOGY_EXACT · 41 trials mapped (14 active)	—	—	Acute Biphenotypic Leukemia	1	Observed	clinicaltrials	graph →

Acute Biphenotypic Leukemia studied in …STUDIED_INderived10 of 41show all (up to 200)

→ studied in

NCT03779854Phase 2 · active not recruiting

Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant · condition mapped ONTOLOGY_EXACT · 41 trials mapped (14 active)

—

Observed

→ studied in

NCT03683433Phase 2 · recruiting

Enasidenib and Azacitidine in Treating Patients With Recurrent or Refractory Acute Myeloid Leukemia and IDH2 Gene Mutation · condition mapped ONTOLOGY_EXACT · 41 trials mapped (14 active)

—

Observed

→ studied in

NCT04128501Phase 2 · active not recruiting

Venetoclax and Azacitidine for the Treatment of Acute Myeloid Leukemia in the Post-Transplant Setting · condition mapped ONTOLOGY_EXACT · 41 trials mapped (14 active)

—

Observed

→ studied in

NCT07819396Phase 2 · not yet recruiting

Depletion of CD45RA Positive Naive T Cells for the Prevention of Graft Versus Host Disease in Older Patients Undergoing Allogeneic Hematopoietic Cell Transplantation for Acute Leukemia or Myelodysplastic Syndrome · condition mapped ONTOLOGY_EXACT · 41 trials mapped (14 active)

—

Observed

→ studied in

NCT05589896Phase 1/Phase 2 · active not recruiting

A First-in-Human Study of HLA-Partially to Fully Matched Allogenic Cryopreserved Deceased Donor Bone Marrow Transplantation for Patients With Hematologic Malignancies · condition mapped ONTOLOGY_EXACT · 41 trials mapped (14 active)

—

Observed

→ studied in

NCT07710781NA · not yet recruiting

Study to Characterize Mismatched to Fully HLA-Matched Ossium HPC, Marrow and Living Donor Transplantation in Patients With Hematologic Malignancies · condition mapped ONTOLOGY_EXACT · 41 trials mapped (14 active)

—

Observed

→ studied in

NCT02159495Phase 1 · active not recruiting

Genetically Modified T-cell Immunotherapy in Treating Patients With Relapsed/Refractory Acute Myeloid Leukemia and Persistent/Recurrent Blastic Plasmacytoid Dendritic Cell Neoplasm · condition mapped ONTOLOGY_EXACT · 41 trials mapped (14 active)

—

Observed

→ studied in

NCT02727803Phase 2 · recruiting

Personalized NK Cell Therapy in CBT · condition mapped ONTOLOGY_EXACT · 41 trials mapped (14 active)

—

Observed

→ studied in

NCT04975919Phase 2 · active not recruiting

Venetoclax in Combination With Decitabine and Cedazuridine for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia · condition mapped CURATED_BROADER · 41 trials mapped (14 active)

—

Observed

→ studied in

NCT03399773Phase 2 · active not recruiting

Infusion of Expanded Cord Blood Cells in Addition to Single Cord Blood Transplant in Treating Patients With Acute Leukemia, Chronic Myeloid Leukemia, or Myelodysplastic Syndromes · condition mapped ONTOLOGY_EXACT · 41 trials mapped (14 active)

—

Observed